Overcoming Therapeutic Inertia in Patients with Hypertension

References

• . The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA. 1977;237(3):255–261
   PubMedGoogle Scholar
• . National Institutes of Health National Heart, Lung, and Blood Institute. Chart Book on Cardiovascular, Lung, and Blood Diseases: Data Points Document. Bethesda, MD: National Institutes of Health; 1996
   Google Scholar
• . National Institutes of Health National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 2007
   Google Scholar
• . Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: The third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol. 2008;18(4):302–309
   PubMedGoogle Scholar
• . World Health Organization. The World Health Report 2002; Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. http://www.who.int/whr/2002/en/whr02_en.pdf. Accessed September 25, 2008
   Google Scholar
• . World Health Organization. Tackling Europe's major diseases: The challenges and the solutions. Geneva, Switzerland: World Health Organization; 2006. http://www.euro.who.int/document/mediacentre/fs0306e.pdf. Accessed September 25, 2008
   Google Scholar
• . Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913
   PubMed Web of Science ®Google Scholar
• . Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–1518
   PubMed Web of Science ®Google Scholar
• . Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49(1):69–75
   PubMed Web of Science ®Google Scholar
• . Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS data brief no 3. Hyattsville, MD: National Center for Health Statistics; 2008
   Google Scholar
• . US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Heart Disease and Stroke: Centers for Disease Control and Prevention National Institutes of Health, Washington, DC: US Government Printing Office; November 2000
   Google Scholar
• . Chobanian AV, Bakris GL, Black HR,; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252
   PubMed Web of Science ®Google Scholar
• . Mancia G, De Backer G, Dominiczak A,; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–1187
   PubMed Web of Science ®Google Scholar
• . ; Blood Pressure Lowering Treatment Trialists' CollaborationTurnbull F, Neal B, Ninomiya T,. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials. BMJ. 2008;336(7653):1121–1123
   PubMed Web of Science ®Google Scholar
• . Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension. 2006;48(2):213–218
   PubMedGoogle Scholar
• . Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290–300
   PubMed Web of Science ®Google Scholar
• . Kjeldsen SE, Dahlöf B, Devereux RB,. Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint. Am J Hypertens. 2000;13(8):899–906
   PubMedGoogle Scholar
• . Cushman WC, Ford CE, Cutler JA,. Success and predictors of blood pressure control in diverse North American settings: The Anti-hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4(6):393–404
   PubMedGoogle Scholar
• . Dahlof B, Sever PS, Poulter NR,; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366(9489):895–906
   PubMed Web of Science ®Google Scholar
• . Douglas JG, Bakris GL, Epstein M,. Management of high blood pressure in African Americans: Consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163(5):525–541
   PubMedGoogle Scholar
• . Jamerson K, Bakris GL, Dahlof B,. Exceptional early blood pressure control rates: The ACCOMPLISH trial. Blood Press. 2007;16(2):80–86
   PubMed Web of Science ®Google Scholar
• . Chrysant SG, Melino M, Karki S, Lee J, Heyrman R. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther. 2008;30(4):587–604
   PubMed Web of Science ®Google Scholar
• . Philipp T, Smith TR, Glazer R,. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007;29(4):563–580
   PubMed Web of Science ®Google Scholar
• . Kotchen TA. From clinical trials to clinical practice: Why the gap? Hypertension. 2006;48(2):196–197
   PubMedGoogle Scholar
• . Pepine CJ, Handberg EM, Cooper-DeHoff RM,; INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA. 2003;290(21):2805–2816
   PubMed Web of Science ®Google Scholar
• . Black HR, Elliott WJ, Grandits G,. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003;289(16):2073–2082
   PubMed Web of Science ®Google Scholar
• . Dahlof B, Devereux RB, Kjeldsen SE,. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 2002;359(9311):995–1003
   PubMed Web of Science ®Google Scholar
• . National Committee for Quality Assurance. The state of health care quality 2007. Washington, DC: National Committee for Quality Assurance; 2007. http://www.ncqa.org/Portals/0/Publications/Resource%20Library/SOHC/SOHC_07.pdf. Accessed September 25, 2008
   Google Scholar
• . Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345–351
   PubMed Web of Science ®Google Scholar
• . Rose AJ, Shimada SL, Rothendler JA,. The accuracy of clinician perceptions of “usual” blood pressure control. J Gen Intern Med. 2008;23(2):180–183
   PubMed Web of Science ®Google Scholar
• . Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: Treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008;117(22):2884–2892
   PubMed Web of Science ®Google Scholar
• . Hosie J, Wiklund I. Managing hypertension in general practice: Can we do better? J Hum Hypertens. 1995;9( suppl 2):S15–S18
   PubMed Web of Science ®Google Scholar
• . Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160(15):2281–2286
   PubMedGoogle Scholar
• . Cushman WC, Basile J. Achieving blood pressure goals: Why aren't we? J Clin Hypertens (Greenwich). 2006;8(12):865–872
   PubMedGoogle Scholar
• . Ofili EO. Dispelling the myth of “aggressive” antihypertensive therapy. J Clin Hypertens (Greenwich). 2006;8(1 suppl 1):4–11
   PubMedGoogle Scholar
• . Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117(1):14–18
   PubMed Web of Science ®Google Scholar
• . Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial. Hypertension. 2009;53(4):646–653
   PubMed Web of Science ®Google Scholar
• . Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, Izzo JL Jr. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich). 2008;10(3):185–194
   PubMed Web of Science ®Google Scholar
• . Weir MR, Weber MA, Nesbitt SD, Hsueh WA, Neutel JM, Jaffe J. Rationale and design of the BP CRUSH study: Evaluating the efficacy and safety of amlodipine/olmesartan medoxomil in patients who are non-responders to anti-hypertensive monotherapy. J Clin Hypertens (Greenwich). 2009; Suppl A 11(4):A137
   Google Scholar
• . Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients: An achievable goal in the Healthy People 2010 report? J Investig Med. 2003;51(6):373–385
   PubMedGoogle Scholar
• . Weber MA. The evolution of combination therapy in treating hypertension. J Clin Hypertens (Greenwich). 2007;9(12 suppl 5):1–4
   PubMedGoogle Scholar